Certara | Accelerating Medicines with Biosimulation and Tech-enabled Services

Certara is the global leader in biosimulation. Since 2014, our customers, who use our software and tech-enabled services, have received 90% of drug and biologic approvals by the FDA. We accelerate medicines by optimizing R&D productivity through model-informed drug development, regulatory science, and market access solutions. Our clients include 1,650+ global biopharmaceutical companies, leading academic institutions, and regulatory agencies across 60 countries.

Home
Since 2014, our customers have received over 90% of new drug and biologic approvals by the FDA

Certara's Better Drug Discovery and Development Process
How we help our clients
Latest from Certara
How can we help you?

0.26817607879639